Bionomics Other Current Liab from 2010 to 2024

BNOX Stock  USD 0.30  0.02  7.14%   
Bionomics Other Current Liabilities yearly trend continues to be fairly stable with very little volatility. Other Current Liabilities will likely drop to about 150.6 K in 2024. During the period from 2010 to 2024, Bionomics Other Current Liabilities regression line of annual values had r-squared of  0.05 and arithmetic mean of  2,975,370. View All Fundamentals
 
Other Current Liabilities  
First Reported
2001-06-30
Previous Quarter
1.5 M
Current Value
1.1 M
Quarterly Volatility
1.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.56. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
  
Check out the analysis of Bionomics Correlation against competitors.

Latest Bionomics' Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Bionomics Ltd ADR over the last few years. It is Bionomics' Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Pretty Stable
   Other Current Liab   
       Timeline  

Bionomics Other Current Liab Regression Statistics

Arithmetic Mean2,975,370
Geometric Mean1,389,793
Coefficient Of Variation95.19
Mean Deviation2,279,475
Median2,092,453
Standard Deviation2,832,330
Sample Variance8T
Range9.2M
R-Value(0.22)
Mean Square Error8.2T
R-Squared0.05
Significance0.44
Slope(138,054)
Total Sum of Squares112.3T

Bionomics Other Current Liab History

2024150.6 K
2023158.5 K
20221.2 M
20211.1 M
2020866.2 K
20194.8 M
20182.8 M

About Bionomics Financial Statements

Bionomics investors use historical fundamental indicators, such as Bionomics' Other Current Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Liabilities158.5 K150.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.